BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 33102205)

  • 1. The Survival Outcomes of T1aN0M0 Triple-Negative Breast Cancer With Adjuvant Chemotherapy.
    Fu WF; Chen QX; Wang XX; Zhang J; Song CG
    Front Oncol; 2020; 10():1753. PubMed ID: 33102205
    [No Abstract]   [Full Text] [Related]  

  • 2. Evaluation of a beneficial effect of adjuvant chemotherapy in patients with stage I triple-negative breast cancer: a population-based study using the SEER 18 database.
    Du ZL; Wang Y; Wang DY; Zhang L; Bian ZM; Deng Y; Xu CS; Lin DC; Xie L; Jia Y; Gao JD; Zhang BL
    Breast Cancer Res Treat; 2020 Sep; 183(2):429-438. PubMed ID: 32647940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of breast surgery on survival of patients with stage IV breast cancer: a SEER population-based propensity score matching analysis.
    Lin Y; Huang K; Zeng Q; Zhang J; Song C
    PeerJ; 2020; 8():e8694. PubMed ID: 32219021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Adjuvant Treatments for T1 N0 M0 Triple-Negative Breast Cancer.
    Zhai Z; Zheng Y; Yao J; Liu Y; Ruan J; Deng Y; Zhou L; Zhao P; Yang S; Hu J; We B; Wu Y; Zhang D; Kang H; Dai Z
    JAMA Netw Open; 2020 Nov; 3(11):e2021881. PubMed ID: 33211105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiotherapy after surgery has significant survival benefits for patients with triple-negative breast cancer.
    Yao Y; Chu Y; Xu B; Hu Q; Song Q
    Cancer Med; 2019 Feb; 8(2):554-563. PubMed ID: 30632300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of adjuvant radiotherapy after breast-conserving surgery in elder women with early-stage breast cancer: a propensity-score matching analysis.
    Han T; Shi M; Chen Q; Chen D; Hao J
    Front Oncol; 2023; 13():1012139. PubMed ID: 37901322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival benefit of adjuvant chemotherapy in elderly patients with stage I triple-negative breast cancer: a cohort study based on the SEER database.
    Zhang Y; Liu X; Ma M; Chen C; Wang X
    Transl Cancer Res; 2023 Jul; 12(7):1741-1752. PubMed ID: 37588733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is breast conservation superior to mastectomy in early stage triple negative breast cancer?
    Saifi O; Chahrour MA; Li Z; Hoballah J; Panoff J; Vallow LA; Zeidan YH
    Breast; 2022 Apr; 62():144-151. PubMed ID: 35182994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The different outcomes between breast-conserving surgery and mastectomy in triple-negative breast cancer: a population-based study from the SEER 18 database.
    Chen QX; Wang XX; Lin PY; Zhang J; Li JJ; Song CG; Shao ZM
    Oncotarget; 2017 Jan; 8(3):4773-4780. PubMed ID: 27999201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of adjuvant radiotherapy after breast-conserving surgery in elderly women with T1-2N0 estrogen receptor-negative breast cancer.
    Chen C; Wang R; Wang B; Wu Y; Jiang J
    PLoS One; 2023; 18(8):e0288078. PubMed ID: 37535561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognosis in different subtypes of metaplastic breast cancer: a population-based analysis.
    He X; Ji J; Dong R; Liu H; Dai X; Wang C; Esteva FJ; Yeung SJ
    Breast Cancer Res Treat; 2019 Jan; 173(2):329-341. PubMed ID: 30341462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of Use and Impact of Chemotherapy in Lymph Node-Negative, T1a Triple-Negative Breast Cancer.
    Bravo-Solarte DC; Zhang F; Anampa JD
    Clin Breast Cancer; 2023 Oct; 23(7):763-773.e6. PubMed ID: 37648557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing survival outcomes between neoadjuvant and adjuvant chemotherapy within T2N1M0 stage hormone receptor-positive, HER2-negative breast cancer: a retrospective cohort study based on SEER database.
    Shang Y; Wang X; Liu Y; Cheng W; Duan Y; Fang Z; Liu J; Kong F; Wang T; Yu T; Hu A; Zhang J; Zhang H; Li M; Rong Z; Li Y; Shakila SS; Li X; Feng J; Ma F; Guo B
    Breast Cancer; 2024 Apr; ():. PubMed ID: 38643430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benefit of adjuvant chemotherapy in lymph node-negative, T1b and T1c triple-negative breast cancer.
    Carbajal-Ochoa W; Bravo-Solarte DC; Bernal AM; Anampa JD
    Breast Cancer Res Treat; 2024 Jan; 203(2):257-269. PubMed ID: 37833449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Postoperative Radiotherapy on Survival of Patients With
    Zhang J; Luo S; Qiu Z; Lin Y; Song C
    Front Oncol; 2021; 11():625628. PubMed ID: 33816261
    [No Abstract]   [Full Text] [Related]  

  • 16. Prognostic role of radiotherapy in low-risk elderly breast cancer patients after breast-conserving surgery: a cohort study.
    Lai X; Han W; Zhang H; Hou J; Wang G; Luo X; Li X; Wang Q; Zhang Y; Wang H; Li Y
    Gland Surg; 2022 May; 11(5):847-859. PubMed ID: 35694094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognosis comparison between intraoperative radiotherapy and whole-breast external beam radiotherapy for T1-2 stage breast cancer without lymph node metastasis treated with breast-conserving surgery: A case-control study after propensity score matching.
    Chen Q; Qu L; He Y; Xu J; Deng Y; Zhou Q; Yi W
    Front Med (Lausanne); 2022; 9():919406. PubMed ID: 35991652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognosis in triple-negative apocrine carcinomas of the breast: A population-based study.
    Wu W; Wu M; Peng G; Shi D; Zhang J
    Cancer Med; 2019 Dec; 8(18):7523-7531. PubMed ID: 31642210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Adjuvant Treatments for Adenoid Cystic Carcinoma of the Breast: A Population-Based, Propensity Score Matched Cohort Study from the SEER Database.
    Yang L; Wang C; Liu M; Wang S
    Diagnostics (Basel); 2022 Jul; 12(7):. PubMed ID: 35885663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local treatment for triple-negative breast cancer patients undergoing chemotherapy: breast-conserving surgery or total mastectomy?
    Guo L; Xie G; Wang R; Yang L; Sun L; Xu M; Yang W; Chung MC
    BMC Cancer; 2021 Jun; 21(1):717. PubMed ID: 34147061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.